Simoa Planar Technology For Ultra-sensitive Quantification Of Biomarkers In Multiplex: Infectious Diseases And Virology
date19 August 2020
Paula Perin, Phd – Quanterix Senior Field Application Scientist | August 19, 2020
Learn More About Groundbreaking Simoa Technology!
You are invited to join Quanterix for a detailed discussion on discovering how to achieve ultra-sensitive protein biomarker quantification in multiplex with the SP-X Imaging and Analysis System and highly-validated CorPlex assay panel or individual cytokine assays.
By enabling accurate measurement of even healthy baseline levels of key inflammatory biomarkers in small volumes of blood or other common sample types, the Quanterix SP-X Imaging and Analysis System is helping researchers of infectious disease answer their most time-sensitive research questions with speed and precision.
Quanterix Senior Field Applications Scientist Paula Perin, PhD explains the technology behind the ultrasensitive Simoa SP-X and its comprehensive panel of assays, which are ideally-suited for the study of low abundance proteins in virology and infectious disease research.
Share this page